Surgery confers survival benefit in De Novo metastatic soft tissue sarcoma patients with low Ki67 or low total lesion glycolysis: a combined PET/CT and clinicopathological analysis - Quiz - MDSpire

Surgery confers survival benefit in De Novo metastatic soft tissue sarcoma patients with low Ki67 or low total lesion glycolysis: a combined PET/CT and clinicopathological analysis

  • By

  • Shaoli Li

  • Xin Zheng

  • Menglei Jin

  • Hui Wang

  • Rui Bai

  • Ying Dong

  • July 10, 2026

  • 0 min

Share

Original Source(s)

Surgery confers survival benefit in De Novo metastatic soft tissue sarcoma patients with low Ki67 or low total lesion glycolysis: a combined PET/CT and clinicopathological analysis

  • by Shaoli Li, Xin Zheng, Menglei Jin, Hui Wang, Rui Bai, Ying Dong

  • July 10, 2026

Related Content

Concurrent B-cell acute lymphoblastic leukemia and plasma cell neoplasm with plasmablastic features supporting divergent evolution from a shared precursor: a case report

Colorectal cancer liver metastases: mechanism and therapy

Editorial: Advancing diagnostic excellence in early lung cancer detection